Fred Middleton
QuietNamed in filings at Mesa Verde Venture PartnersOn the current fund
- Board seats filed
Named in filings at Mesa Verde Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| CalciMedica | Biotech & pharma | March 2023 | None on file |
| Theravida | Not yet classified | January 2023 | None on file |
| HCW Biologics | Not yet classified | September 2020 | None on file |
| CalciMedica | Not yet classified | May 2020 | None on file |
| CHIMERIX | Not yet classified | July 2019 | None on file |
| Actimis Pharmaceuticals | Not yet classified | March 2017 | None on file |
| Stereotaxis | Not yet classified | September 2016 | None on file |
| CoMentis | Not yet classified | March 2016 | None on file |
| LineaGen | Biotech & pharma | January 2015 | High Alpha |
| Altor Bioscience | Not yet classified | October 2014 | None on file |
| ViaCyte | Biotech & pharma | August 2014 | Bain Capital Life Sciences, Thayer Ventures |
| AXIKIN PHARMACEUTICALS | Not yet classified | March 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Fred Middleton on the board, based on 3 filed seats with a verified or cited source.
9 more filed seats not yet classified, left out of the shares above.